These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6279049)

  • 1. Impaired presynaptic regulation of norepinephrine in schizophrenia. Effects of clonidine in schizophrenic patients and normal controls.
    Sternberg DE; Charney DS; Heninger GR; Leckman JF; Hafstad KM; Landis DH
    Arch Gen Psychiatry; 1982 Mar; 39(3):285-9. PubMed ID: 6279049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.
    Charney DS; Heninger GR; Sternberg DE; Hafstad KM; Giddings S; Landis DH
    Arch Gen Psychiatry; 1982 Mar; 39(3):290-4. PubMed ID: 6279050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment.
    Charney DS; Heninger GR; Sternberg DE; Redmond DE; Leckman JF; Maas JW; Roth RH
    Arch Gen Psychiatry; 1981 Dec; 38(12):1334-40. PubMed ID: 6274268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clonidine on central and peripheral catecholamine metabolism.
    Martin PR; Ebert MH; Gordon EK; Linnoila M; Kopin IJ
    Clin Pharmacol Ther; 1984 Mar; 35(3):322-7. PubMed ID: 6199153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenergic responses to clonidine in acute and remitted depressed male patients.
    Trestman RL; Lawrence TL; Coccaro EF; Harvey P; Bernstein D; Lawrence EK; Condello V; Mahon T; Yang RK; Knott P
    Psychiatry Res; 1992 Sep; 43(3):199-213. PubMed ID: 1332095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine treatment of schizophrenia: can we predict treatment response?
    van Kammen DP; Peters JL; van Kammen WB; Rosen J; Yao JK; McAdam D; Linnoila M
    Psychiatry Res; 1989 Mar; 27(3):297-311. PubMed ID: 2469097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine.
    Siever LJ; Uhde TW
    Biol Psychiatry; 1984 Feb; 19(2):131-56. PubMed ID: 6324896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-2 adrenergic receptor sensitivity and the mechanism of action of antidepressant therapy. The effect of long-term amitriptyline treatment.
    Charney DS; Heninger GR; Sternberg DE
    Br J Psychiatry; 1983 Mar; 142():265-75. PubMed ID: 6305451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects.
    Siever LJ; Uhde TW; Jimerson DC; Lake CR; Silberman ER; Post RM; Murphy DL
    Am J Psychiatry; 1984 Jun; 141(6):733-41. PubMed ID: 6329004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
    Roth RH; Elsworth JD; Redmond DE
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):42-6. PubMed ID: 6806253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of 3-methoxy-4-hydroxyphenylglycol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradrenaline utilisation and presynaptic alpha 2-adrenoceptor function.
    Heal DJ; Prow MR; Buckett WR
    Br J Pharmacol; 1989 Mar; 96(3):547-56. PubMed ID: 2541844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
    Coplan JD; Papp LA; Pine D; Martinez J; Cooper T; Rosenblum LA; Klein DF; Gorman JM
    Arch Gen Psychiatry; 1997 Jul; 54(7):643-8. PubMed ID: 9236548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal responses to clonidine and urinary MHPG in delusional and nondelusional melancholic patients: a placebo-controlled study.
    Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):77-81. PubMed ID: 1657199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma 3-methoxy-4-hydroxyphenylglycol changes associated with clinical state and schizophrenic subtype.
    Ko GN; Jimerson DC; Wyatt RJ; Bigelow LB
    Arch Gen Psychiatry; 1988 Sep; 45(9):842-6. PubMed ID: 3415425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet alpha 2-adrenergic receptors in schizophrenic patients before and after phenothiazine treatment.
    Rice HE; Smith CB; Silk KR; Rosen J
    Psychiatry Res; 1984 May; 12(1):69-77. PubMed ID: 6087398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of clonidine on plasma MHPG: evidence against tonic alpha 2-adrenoceptor control of noradrenergic function.
    Nutt DJ; Molyneux SG
    Psychopharmacology (Berl); 1986; 90(4):509-12. PubMed ID: 3027736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired noradrenergic transmission in schizophrenia?
    van Kammen DP; Antelman S
    Life Sci; 1984 Apr; 34(15):1403-13. PubMed ID: 6323903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covariance of plasma free 3-methoxy-4-hydroxyphenethyleneglycol and diastolic blood pressure.
    Leckman JF; Maas JW; Heninger GR
    Eur J Pharmacol; 1981 Mar; 70(2):111-20. PubMed ID: 7262184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of norepinephrine turnover from alpha-2 responses after clorgiline.
    Hauger RL; Scheinin M; Siever LJ; Linnoila M; Potter WZ
    Clin Pharmacol Ther; 1988 Jan; 43(1):32-8. PubMed ID: 2826065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.
    Raskind MA; Peskind ER; Halter JB; Jimerson DC
    Arch Gen Psychiatry; 1984 Apr; 41(4):343-6. PubMed ID: 6703854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.